Tower Research Capital LLC (Trc) Artivion, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Artivion, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,130 shares of AORT stock, worth $51,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,130
Previous 3,738
43.02%
Holding current value
$51,375
Previous $99,000
38.38%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AORT
# of Institutions
176Shares Held
37.1MCall Options Held
29.9KPut Options Held
2.3K-
Black Rock Inc. New York, NY6.64MShares$160 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$67.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$67.4 Million2.68% of portfolio
-
Macquarie Group LTD Australia, C32.74MShares$66 Million0.09% of portfolio
-
Morgan Stanley New York, NY2.36MShares$56.9 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $972M
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...